Trump Launches TrumpRx Website Offering Massive Drug Price Cuts

Unprecedented Drug Price Reductions

President Donald Trump unveiled TrumpRx.gov on Thursday, a government website promising to deliver dramatic prescription drug savings to American consumers. The platform allows patients to access large discounts on many of the most popular and highest-priced medicines in the country, paying prices in line with the lowest paid by other developed nations. The website represents the culmination of Trump's year-long pressure campaign against pharmaceutical companies, using tariff exemptions as leverage to secure pricing concessions.

As of today, patients purchasing directly through TrumpRx.gov will be able to see massive price reductions on 40 of the most popular and expensive branded medicines in the nation. The savings are particularly striking for weight-loss medications that have captured national attention. The monthly prices of Ozempic and injectable Wegovy will fall from $1,028 and $1,349, respectively, to an average price of $350 and as low as $199, depending on dosage strength. The monthly price of Zepbound will fall from $1,088 to an average price of $346 and as low as $299, depending on dosage strength.

Beyond obesity treatments, the site offers substantial discounts across therapeutic categories. Bevespi Aerosphere, an inhaler used to treat chronic obstructive pulmonary disease (COPD), will be discounted from $458 to $51. Airsupra, an inhaler used to treat asthma symptoms and attacks, will see a price drop from $504 to $201. For families struggling with infertility, many patients struggling with infertility pay for their medicines out-of-pocket, meaning they will stand to save more than $2,000 per cycle of fertility drugs, on average.

How the System Works

The site is not selling drugs directly to American patients, but will act as a central hub that points them to drugmakers that are offering discounts on certain products on their own direct-to-consumer sites. Instead, it offers coupons that people can take to the pharmacy where they fill their prescriptions. The platform uses technology from GoodRx and includes medications from companies that have struck deals with the administration.

Today's launch features drugs made by the first five manufacturers to reach MFN pricing deals with the Trump Administration: AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer. Additional drugs from other companies that have signed MFN pricing deals will be made available through TrumpRx.gov in the coming months. In exchange for exemptions from certain tariffs, the drugmakers agreed to lower prices for Medicaid, to launch future new drugs at prices no higher than those paid in other wealthy countries and to offer discounts through TrumpRx to patients paying cash for their medicines.

Limited Benefits for Many Patients

Despite the dramatic price cuts, experts caution that TrumpRx may offer limited value for most Americans. There's no clear advantage for most people to use TrumpRx to purchase their medications. That's because, for most people — especially most with health insurance — it would be hard for direct-to-consumer prices to beat the cost-sharing amounts that they'll pay using their insurance. The website itself acknowledges this reality, noting "If you have insurance, check your co-pay first—it may be even lower."

What people with insurance spend through TrumpRx may not count toward their insurance benefits, which means it doesn't help them meet their deductibles or out-of-pocket maximums. Additionally, some medications featured on the site already have cheaper generic alternatives available through other discount platforms. Some of the drugs are already available as inexpensive generics, such as Protonix for heartburn and gastroesophageal reflux disease, which is available for $200 on TrumpRx. The generic version, called pantoprazole, costs $30 with a coupon from GoodRx.

Real Impact for Specific Populations

The platform shows genuine promise for patients whose medications aren't covered by insurance. For people whose drugs aren't covered by their insurance plans — such as those who need to undergo fertility treatments or need an obesity drug — TrumpRx and other cash-pay discounts can help. So for those types of medicines, there is a market for patients who want to access those medicines and don't really have an option or insurance.

The fertility drug discounts represent particularly significant savings. The fertility drug discount is legitimately a big deal for people trying to get IVF. These medicines are quite expensive and this seems like a big discount. In general IVF is not covered by insurance and so people prior to this who needed certain drugs would be paying the full $1400 price. For these specific populations, TrumpRx could provide meaningful relief from crushing medication costs that have long been barriers to essential treatments.